Open AccessComparative Cost Effectiveness of Reflux-Based and Reflux-Independent Strategies for Barrett's Esophagus Screening
Author(s) -
Sarmed S. Sami,
James P. Moriarty,
Jordan K. Rosedahl,
Bijan J. Borah,
David A. Katzka,
Linghua Wang,
John B. Kisiel,
Krish Ragunath,
Joel H. Rubenstein,
Prasad G. Iyer
Publication year - 2021
Publication title -
the american journal of gastroenterology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.907
H-Index - 252
eISSN - 1572-0241
pISSN - 0002-9270
DOI - 10.14309/ajg.0000000000001336
Subject(s) - gerd , medicine , barrett's esophagus , esophagus , reflux , cost effectiveness , cohort , esophageal disease , disease , gastroenterology , cancer , adenocarcinoma , risk analysis (engineering)
Minimally invasive tests for Barrett's esophagus (BE) detection have raised the prospect of broader nonreflux-based testing. Cost-effectiveness studies have largely studied men aged 50 years with chronic gastroesophageal reflux disease (GERD) symptoms. We evaluated the comparative cost effectiveness of BE screening tests in GERD-based and GERD-independent testing scenarios.